H.R. 2821 · 119th Congress

FDA Modernization Act 3.0

Stage
Passed a chamber
Sponsor
Buddy Carter
Introduced
2025-04-10
Latest action
2026-07-21 · Received in the Senate.

Action history

  1. 2026-07-21Received in the Senate.
  2. 2026-07-21Received in the Senate.
  3. 2026-07-20Motion to reconsider laid on the table Agreed to without objection.
  4. 2026-07-20On motion to suspend the rules and pass the bill Agreed to by voice vote.
  5. 2026-07-20DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
  6. 2026-07-20Considered under suspension of the rules.
  7. 2026-07-20Mr. Guthrie moved to suspend the rules and pass the bill.
  8. 2026-06-18Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
  9. 2026-06-18Placed on the Union Calendar, Calendar No. 614.
  10. 2026-06-18Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
  11. 2026-06-18Placed on the Union Calendar, Calendar No. 614.
  12. 2026-05-21Committee Consideration and Mark-up Session Held
  13. 2026-05-21Ordered to be Reported by the Yeas and Nays: 44 - 0.
  14. 2026-05-21Committee Consideration and Mark-up Session Held
  15. 2026-05-21Ordered to be Reported by the Yeas and Nays: 44 - 0.
  16. 2026-05-13Subcommittee Consideration and Mark-up Session Held
  17. 2026-05-13Forwarded by Subcommittee to Full Committee by Voice Vote.
  18. 2026-05-13Subcommittee Consideration and Mark-up Session Held
  19. 2026-05-13Forwarded by Subcommittee to Full Committee by Voice Vote.
  20. 2026-04-10Referred to the Subcommittee on Health.
  21. 2026-04-10Referred to the Subcommittee on Health.
  22. 2025-04-10Introduced in House
  23. 2025-04-10Referred to the House Committee on Energy and Commerce.
  24. 2025-04-10Introduced in House
  25. 2025-04-10Referred to the House Committee on Energy and Commerce.